home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
hicn709.zip
/
HICN709.TXT
< prev
Wrap
Text File
|
1994-03-25
|
39KB
|
805 lines
HICNet Medical News Digest Fri, 18 Mar 1994 Volume 07 : Issue 09
Today's Topics:
[MMWR] Impact of Expanded AIDS Definition on Case Reporting
[MMWR] Measles and Measles Elimination Program
Conference: Emerging Technologies in Medicine & Biology
WHO Collaborating on Non-Communicable Disease Program
CancerNet Update
Institute of Tropical Medicine Epidemiological Bulletin 8 Jan 94
+------------------------------------------------+
! !
! Health Info-Com Network !
! Medical Newsletter !
+------------------------------------------------+
Editor: David Dodell, D.M.D.
10250 North 92nd Street, Suite 210, Scottsdale, Arizona 85258-4599 USA
Telephone +1 (602) 860-1121
FAX +1 (602) 451-1165
Compilation Copyright 1994 by David Dodell, D.M.D. All rights Reserved.
License is hereby granted to republish on electronic media for which no
fees are charged, so long as the text of this copyright notice and license
are attached intact to any and all republished portion or portions.
The Health Info-Com Network Newsletter is distributed biweekly. Articles
on a medical nature are welcomed. If you have an article, please contact
the editor for information on how to submit it. If you are interested in
joining the automated distribution system, please contact the editor.
E-Mail Address:
Editor:
Internet: david@stat.com
FidoNet = 1:114/15
Bitnet = ATW1H@ASUACAD
LISTSERV = MEDNEWS@ASUACAD.BITNET (or internet: mednews@asuvm.inre.asu.edu)
anonymous ftp = vm1.nodak.edu
Notification List = hicn-notify-request@stat.com
FAX Delivery = Contact Editor for information
----------------------------------------------------------------------
Date: Fri, 18 Mar 94 23:24:52 MST
From: mednews (HICNet Medical News)
To: hicnews
Subject: [MMWR] Impact of Expanded AIDS Definition on Case Reporting
Message-ID: <6Z9eJc7w165w@stat.com>
Update: Impact of the Expanded AIDS Surveillance
Case Definition for Adolescents and Adults
on Case Reporting -- United States, 1993
During 1993, local, state, and territorial health departments reported
103,500 acquired immunodeficiency syndrome (AIDS) cases among persons aged
greater than or equal to 13 years in the United States, an increase of 111%
over the 49,016 reported in 1992 (Figure 1). This increase resulted from the
expansion of the AIDS surveillance case definition in 1993*; in comparison,
the number of cases based on the preexisting case definition decreased
slightly. This report summarizes characteristics of persons reported with AIDS
in 1993, compares these findings with data from 1992, and describes the impact
of the change in the AIDS surveillance definition on AIDS case reporting.**
Of cases in 1993, 55,432 (54%) were reported based on conditions added to
the definition in 1993; and 48,068 (46%) were reported based on pre-1993
defined conditions--a 2% decrease from the number of cases reported in 1992
(Figure 1). Of the 55,432 cases reported based on 1993-added conditions,
50,061 persons (91%) had severe human immunodeficiency virus (HIV)-related
immunosuppression only; 3988 (7%), pulmonary tuberculosis (TB); 1251 (2%),
recurrent pneumonia; and 151 ( less than 1%), invasive cervical cancer (19
persons were reported with more than one of these opportunistic illnesses).
The number of case reports was highest during the first quarter of 1993
(n=33,875, a 178% increase over the same period in 1992) and declined
throughout the year: 18,957 cases were reported during the fourth quarter, a
67% increase over the same period in 1992. Comparing the same quarters of
1993, the median interval between date of diagnosis and date of report
declined from 9 months to 4 months among persons reported with the newly added
criteria but remained stable for persons reported using pre-1993 criteria. Of
the cases reported in 1993, 56% had been diagnosed in earlier years, compared
with 42% of cases reported in 1992.
In 1993, substantial increases in the number of reported AIDS cases
occurred in all regions of the United States (Table 1, page 168). Of areas
reporting more than 250 cases, the proportion of cases based on the 1993-added
criteria ranged from 35% in North Carolina (n=1353) to 71% in Colorado
(n=1323).
The increase in reported cases in 1993 was greater among females (151%)
than among males (105%) (Table 1, page 168). Proportionate increases were
greater among blacks and Hispanics than among whites. The largest increases in
case reporting occurred among persons aged 13-19 years and 20-24 years; in
these age groups, a greater proportion of cases were reported among women (35%
and 29%, respectively) and were attributed to heterosexual transmission (22%
and 18%, respectively).
Compared with homosexual/bisexual men, proportionate increases in case
reporting were greater among heterosexual injecting-drug users (IDUs) and
among persons reportedly infected through heterosexual contact (Table 1). The
largest proportionate increase in AIDS case reporting occurred among persons
with hemophilia, although the total number of these cases was smaller than for
the other HIV-exposure categories.
Females, blacks, heterosexual IDUs, and persons with hemophilia were more
likely than others to be reported with 1993-added conditions (Table 2). Most
of these differences were attributable to reports of the three opportunistic
illnesses added in 1993; of 5371 persons reported with a 1993-added
opportunistic illness, 26% were women, 48% were heterosexual IDUs, and 63%
were black. The number of Hispanics reported under the 1993-added criteria
reflected reports from Puerto Rico: 38% of the 3173 reports from Puerto Rico
were based on the 1993-added criteria, compared with 54% of the 15,145 cases
among Hispanics from other areas.
The pediatric AIDS surveillance case definition was not changed in 1993.
During 1993, 968 children aged less than 13 years were reported with AIDS, an
increase of 24% compared with the 783 cases reported in 1992. Of those 968
children, 50% were female, and most were either black (55%) or Hispanic (27%)
and were infected through perinatal HIV transmission (93%). New York, Puerto
Rico, and Florida reported 489 (51%) of the pediatric AIDS cases.
Reported by: Local, state, and territorial health depts. Div of HIV/AIDS,
National Center for Infectious Diseases, CDC.
Editorial Note: The expansion of AIDS surveillance criteria in 1993 altered
both the process of AIDS surveillance and the number of reported cases. The
dramatic increase in the number of cases reported probably represents a one-
time effect of the expanded reporting criteria that primarily results from
reporting of persons who had newly added conditions diagnosed before 1993.
The increase in the number of cases reported in 1993 (111%) exceeded the
projected increase (75%) (1,2), indicating the rapid and efficient
implementation of the revised AIDS surveillance criteria by many local and
state health departments. Because the initial impact of the expanded case
definition is likely to wane, the number of AIDS cases reported in 1994 is
expected to be less than the number reported in 1993.
During 1993, the number of reported cases meeting the pre-1993 AIDS
surveillance definition decreased 2% from 1992. This reflects the rapid
adoption of the CD4+ reporting criteria, which was used for 91% of AIDS case
reports that were based on the 1993-added conditions. Therefore, the case
count using pre-1993 criteria is not a precise measure of the number of cases
that would have been reported if the definition had not been changed because
the reporting of conditions meeting the pre-1993 criteria is affected by
reporting using the CD4+ and other expanded criteria. For example, some cases
reported under the expanded criteria may have had a concurrent or subsequent
AIDS-defining condition in 1993 that was not reported; conversely, reporting
of these pre-1993 conditions may have been enhanced by follow-up of cases
initially reported with a newly added condition.
In addition to active surveillance in hospitals and outpatient clinics,
local health departments have employed different methods and sources to
implement the expanded reporting criteria; these include laboratory-initiated
surveillance for HIV antibody and CD4+ measurements (in states that require
such reporting) and for AIDS-defining opportunistic infections and information
obtained from TB and cancer surveillance registries (3,4). Group-specific
differences may exist in the incidence of 1993-added conditions and in access
to and use of HIV testing and clinical-care services. For example, the large
increase in AIDS reporting among persons with hemophilia may reflect high
levels of HIV testing and immunologic monitoring in this population in which
new HIV infections have been rare since 1985. Females, IDUs, and blacks were
most likely to be reported with new AIDS-defining opportunistic illnesses.
This difference largely reflects the population coinfected with Mycobacterium
tuberculosis and HIV (5).
In 1993, the rate of increase in case reporting was greatest for women,
racial/ethnic minorities, adolescents, IDUs, and persons infected through
heterosexual contact. These trends in AIDS case reporting are similar to those
observed in previous reporting years and suggest that changes in 1993 reflect,
in part, underlying changes in the epidemic. Because race and ethnicity are
not risk factors for HIV infection, an assessment of risk behaviors is
necessary to properly target prevention efforts. The higher incidence of AIDS
among non-Hispanic blacks and Hispanics than among non-Hispanic whites
emphasizes the need for culturally sensitive and appropriate prevention
messages. Although the pediatric case definition remained unchanged in 1993,
the number of children reported with AIDS increased and paralleled the
increase in AIDS among women.
The surveillance information available as a result of the expanded AIDS
reporting criteria provides a representative and more complete estimate of the
number and distribution of persons with severe HIV-related immunosuppression
and three major HIV-related illnesses that are particularly important among
groups in whom the growth of the AIDS epidemic has been greatest. In general,
persons with 1993-added conditions had higher CD4+ counts than other persons
with AIDS. The ability to conduct surveillance for persons in earlier stages
of HIV infection should result in more prompt recognition of changes in the
trends of HIV transmission and disease. The expanded reporting criteria also
have made reporting more complete because persons with 1993-added conditions
who had died would not have been reported if the AIDS surveillance definition
had not been changed. The addition of the pulmonary TB reporting criteria has
more than doubled the number of persons with AIDS reported with TB. Although
the number of HIV-infected women reported with invasive cervical cancer is
relatively small, the inclusion of this potentially preventable and life-
threatening condition in AIDS surveillance efforts provides an opportunity to
monitor gynecologic care for HIV-infected women. The expanded AIDS
surveillance information should facilitate community efforts to plan, direct,
and evaluate HIV-prevention and HIV-care programs.
References
1. CDC. 1993 Revised classification system for HIV infection and expanded
surveillance case definition for AIDS among adolescents and adults. MMWR
1992;41(no. RR-17).
2. CDC. Impact of the expanded AIDS surveillance case definition on AIDS case
reporting--United States, first quarter, 1993. MMWR 1993;42:308-10.
3. CDC. Assessment of laboratory reporting to supplement active AIDS
surveillance--Colorado. MMWR 1993;42:749-52.
4. Trino R, McAnaney J, Fife D. Laboratory-based reporting of AIDS. J Acquir
Immune Defic Syndr 1993;6:1057-61.
5. Slutsker L, Castro KG, Ward JW, Dooley SW. Epidemiology of extrapulmonary
tuberculosis among persons with AIDS in the United States. Clin Infect Dis
1993;16:513-8.
* On January 1, 1993, the AIDS surveillance case definition for adolescents
and adults was expanded beyond the definition published in 1987 to include all
human immunodeficiency virus-infected persons with severe immunosuppression
(less than 200 CD4+ T-lymphocytes/microliter or a CD4+ T-lymphocyte percentage
of total lymphocytes of less than 14), pulmonary tuberculosis, recurrent
pneumonia, or invasive cervical cancer (1).
** Single copies of this report will be available free until March 11, 1995,
from the CDC National AIDS Clearinghouse, P.O. Box 6003, Rockville, MD 20849-
6003; telephone (800) 458-5231.
------------------------------
Date: Fri, 18 Mar 94 23:25:57 MST
From: mednews (HICNet Medical News)
To: hicnews
Subject: [MMWR] Measles and Measles Elimination Program
Message-ID: <y29eJc8w165w@stat.com>
Measles -- Puerto Rico, 1993,
and the Measles Elimination Program
In the Commonwealth of Puerto Rico, a resurgence of measles peaked in
1990 when 1805 cases (51.3 cases per 100,000 population) and 12 measles-
related deaths were reported. This report summarizes the persistence of
measles transmission in Puerto Rico in 1993 and describes the Puerto Rico
Measles Elimination Program.
Because of similarities in clinical features of measles and dengue (which
is endemic in Puerto Rico [1]), since 1991 only measles cases serologically
confirmed by enzyme-linked immunosorbent assay have been reported to CDC. In
1993, 355 measles cases were reported (10.1 per 100,000). Cases were reported
from each region of Puerto Rico (Figure 1); the largest outbreaks were
reported from Arecibo (219 cases [53.7 per 100,000]), Ponce (46 [8.2]), and
Metropolitan (including San Juan) (31 [3.7]). Confirmed cases were reported in
each month; nearly half of all cases occurred during April (48 cases), May
(77), and June (52); fewer than 10 cases occurred each month during October-
December.
Most (254 [72%]) cases occurred among preschool-aged children (i.e., aged
0-5 years); 116 (33%) occurred among infants (i.e., aged less than 12 months).
Among the 248 (70%) persons with measles for whom vaccination status was
known, 149 (60%) were unvaccinated; these unvaccinated persons constituted 93%
of infants, 56% of children aged 1-5 years, 2% of school-aged children, and
64% of adults (Table 1).
From 1983 to 1990, Puerto Rico required one dose of measles-mumps-rubella
vaccine (MMR) for school entry, and annual audits during 1990-1992 indicated
approximately 95% coverage among children in all grades. Since 1990, two doses
of MMR have been required for school entry, and annual audits during 1991-1992
indicated approximately 90% coverage with two doses among children entering
school. In 1990, Puerto Rico lowered the recommended age for routine
vaccination with MMR to 12 months. Vaccination coverage with one dose of MMR
by 24 months (estimated by retrospective studies of children entering school
in 1992) was 69%.
To eliminate indigenous measles transmission in Puerto Rico by 1996, the
Puerto Rico Department of Health (PRDH) is conducting the Puerto Rico Measles
Elimination Program, an islandwide effort comprising a mass vaccination
campaign, increased measles surveillance, and aggressive outbreak control.
Reported by: C Feliciano, MD, Secretary of Health; E Pintado Diaz, MD, Central
Office of AIDS and Communicable Diseases Affairs; E Calderon, V Rodriguez,
Immunization Program; C Deseda, MD, Measles Elimination Program; C Rodriguez,
Div of Epidemiology; JV Rullan, MD, Commonwealth Epidemiologist, Puerto Rico
Dept of Health. National Immunization Program; Div of Vector-Borne Infectious
Diseases, National Center for Infectious Diseases, CDC.
Editorial Note: Elimination of indigenous measles in the United States by 1996
is a goal of the Childhood Immunization Initiative (2). The approach adopted
in Puerto Rico to meet this objective is based on a measles-elimination
strategy advocated by the Pan American Health Organization (PAHO). This
strategy, implemented by 14 Latin American countries and all 17 English-
speaking Caribbean countries, supplements routine vaccination with mass
vaccination campaigns for children aged less than 15 years regardless of
previous vaccination status and enhances surveillance for febrile rash
illness. Since September 1991, no confirmed indigenous measles cases have been
reported from the English-speaking Caribbean countries or Cuba (Expanded
Program on Immunization, PAHO, unpublished data, 1994).
Because effective school vaccination laws have resulted in high (greater
than 90%) MMR coverage among all school-aged children in Puerto Rico, PRDH
will focus its mass vaccination campaign on preschool-aged children, among
whom most (72%) of the recent cases have occurred. This campaign, scheduled
for March 16-19, 1994, will target the approximately 353,000 children in
Puerto Rico aged 6 months-5 years, regardless of previous measles vaccination
history. In addition, health-care providers will assess vaccination status of
children for whom records are available for oral poliovirus vaccine,
diphtheria and tetanus toxoids and pertussis vaccine, and Haemophilus
influenzae type b vaccine and will administer needed vaccines. Following the
campaign, PRDH will conduct a population-based evaluation of the vaccination
coverage achieved.
Other elements of the measles elimination program in Puerto Rico are to
increase measles surveillance and to implement aggressive outbreak control.
PRDH will establish a febrile rash illness reporting system. All health-care
providers will be encouraged to promptly report to PRDH every case of febrile
rash illness, which will be investigated within 24 hours of report. Measles
surveillance will continue to be coordinated with the PRDH Community Hygiene
Division (which conducts dengue surveillance) and CDC's Dengue Branch,
Division of Vector-Borne Infectious Diseases, National Center for Infectious
Diseases, in San Juan to provide additional laboratory diagnosis of cases of
rash illness. Private laboratories will be requested to notify PRDH on receipt
of any specimen submitted for measles serology. A case-response protocol will
enable PRDH to implement outbreak-control measures as soon as a diagnosis of
measles is considered likely--ideally within 3 days of rash onset. Control
measures will include enhanced case investigation, contact tracing, and
vaccination of contacts.
Because measles may circulate independently among older vaccinated
persons (without a reservoir of susceptible preschool-aged children to sustain
transmission), measles circulation in Puerto Rico could persist despite a
successful mass vaccination campaign. Enhanced surveillance efforts will be
needed to identify this trend and to stimulate development of additional
strategies to interrupt transmission. In addition, continued efforts to
improve timely vaccination of preschool-aged children will be necessary to
maintain the high vaccination coverage level anticipated following the
campaign.
References
1. Dietz VJ, Nieburg P, Gubler DJ, Gomez I. Diagnosis of measles by clinical
case definition in dengue-endemic areas: implications for measles surveillance
and control. Bull World Health Organ 1992;47:745-50.
2. CDC. Reported vaccine-preventable diseases--United States, 1993, and the
Childhood Immunization Initiative. MMWR 1994;43:57-60.
------------------------------
Date: Fri, 18 Mar 94 23:26:28 MST
From: mednews (HICNet Medical News)
To: hicnews
Subject: Conference: Emerging Technologies in Medicine & Biology
Message-ID: <T39eJc9w165w@stat.com>
****************************************************************************
* *
* Artificial Neural Networks in Engineering (ANNIE '94) *
* St. Louis, Missouri, November 13-16, 1994 *
* *
* Announcement of The New Track *
* "Emerging Technologies in Medicine and Biology" *
****************************************************************************
Dear Colleague,
I am organizing a new track on EMERGING TECHNOLOGIES IN MEDICINE AND
BIOLOGY for the upcoming Artificial Neural Networks in Engineering (ANNIE'94)
Conference to be held in St Louis, Missouri, November 13-16, 1994.
This new track will include five special sessions:
1. Time-Frequency and Wavelet Transforms in ENGINEERING, MEDICINE and BIOLOGY.
2. Fuzzy Logic in MEDICINE and BIOLOGY.
3. Neural Networks and Artificial Intelligence in MEDICINE and BIOLOGY.
4. Virtual Really in ENGINEERING, MEDICINE and BIOLOGY.
5. Chaos and Fractals in ENGINEERING, MEDICINE and BIOLOGY.
If you are interested in submitting a paper or papers to this track,
please send a letter of intent, an information sheet that includes the
full name of the author(s), title, address, phone number and FAX or e-mail
address (if applicable) by March 21, 1994 to:
Dr. Cihan Dagli, Conference Chair
223 Engineering Management Building
University of Missouri-Rolla
Rolla, MO 65401-0249 USA
Phone:(314) 341-4374
Fax: (314) 341-6567
e-mail:dagli@shuttle.cc.umr.edu
and one copy to me
Dr. Metin Akay, Organizing Committee Member
Biomedical Engineering Debt.
Rutgers University
P.O. Box. 909
Piscawatay, NJ 08854
Phone:(908) 932-4906
Fax: (908) 235-7048
e-mail:akay@gandalf.rutgers.edu
Full papers are due by May 20, 1994. Authors will be notified of the status of
their submittal by July 8, 1994 and camera-ready papers will be due by August
12, 1994. Approximately six to eight pages will be allocated for each accepted
paper in the proceedings.
I hope you will be able to join us in what promises to be an exciting meeting
discussing the recent advances in Biomedical Engineering Research.
Looking forward to hearing from you.
Sincerely,
Metin Akay, Ph.D.
Visiting Professor
Biomedical Engineering Dept.
Rutgers University
P.O. Box. 909
Piscawatay, NJ 08854
Phone:(908) 932-4906
Fax: (908) 235-7048
e-mail:akay@gandalf.rutgers.edu
------------------------------
Date: Fri, 18 Mar 94 23:27:12 MST
From: mednews (HICNet Medical News)
To: hicnews
Subject: WHO Collaborating on Non-Communicable Disease Program
Message-ID: <249eJc10w165w@stat.com>
WHO COLLABORATING CENTERS
ON NON-COMMUNICABLE DISEASES
DISCUSSION GROUP
WHONCD-L
The Division of Health and Development of the Pan American Health Organization
(PAHO) is pleased to announce to all participants at WHO Collaborating Centers
on Non Communicable Diseases that the discussion group list WHONCD-L has been
deployed at db2.nlm.nih.gov server as a part of the recommendation of the
meeting.
Your messages should be addressed to whoncd-l@db2.nlm.nih.gov and the Server
will automatically distribute it among the participants. We hope to improve
later with specific networks on specialized areas of interest.
We hope that the WHONCD-L will be a useful instrument to share, exchange and
promote information among WHO Collaborating Centers in USA and Canada with the
Latin America and Caribbean research community.
We would like to thank all WHO Collaborating Centers Directors for their
relevant contributions, suggestions and recommendation oriented to support
more dynamic information access on scientific matters. Let us be simple to
start with.
To subscribe to WHONCD-L please send an E-mail to:
listserv@db2.nlm.nih.gov
and in the body of the letter type:
subscribe whoncd-l following with your name
For more information about this discussion group please contact Dr. Carlos A.
Gamboa <gamboa@nlm.nih.gov>
------------------------------
Date: Fri, 18 Mar 94 23:28:02 MST
From: mednews (HICNet Medical News)
To: hicnews
Subject: CancerNet Update
Message-ID: <F69eJc11w165w@stat.com>
*************************************************
* NATIONAL INSTITUTE *
* C A N C E R *
* INTERNATIONAL INFORMATION *
* C E N T E R *
*************************************************
* Cancernet@icicb.nci.nih.gov *
**********************************
**************************************************************************
* The National Cancer Institute staff responsible for the pilot study *
* of PDQ use would like to thank all users of CancerNet who responded *
* to our request to participate in the survey of PDQ use and user *
* satisfaction. The survey of CancerNet users is now completed. *
* If you were not among the few randomly selected to participate *
* in the current survey, we may contact you in the future to ask *
* your cooperation in responding to a much larger survey of PDQ *
* users that is planned. *
**************************************************************************
The National Cancer Institute has a new Information Associates Program
which provides one-stop, easy access to all of NCI's scientific
information resources, including online access to the PDQ database
via the Internet or by dialing toll-free to NCI using just a
modem and personal computer. Request news article cn-400035
(U.S. Residents) or cn-400036 ( International) for details.
CancerNet has been updated for March. The following statements
were modified.
Changed Cancer Information Statements:
Adult brain tumor cn-101143
Adult Hodgkin's disease cn-100003
Adult non-Hodgkin's lymphoma cn-100066
Bladder cancer cn-101206
Breast cancer cn-100013
Cervical cancer cn-100103
Childhood acute lymphocytic leukemia cn-100026
Childhood acute myeloid leukemia cn-101081
Childhood brain tumor cn-100047
Childhood rhabdomyosarcoma cn-100759
Colon cancer cn-100008
Endometrial cancer cn-101176
Hairy cell leukemia cn-101651
Hypopharyngeal cancer cn-101500
Laryngeal cancer cn-101519
Lip and oral cavity cancer cn-102840
Malignant mesothelioma cn-101071
Neuroblastoma cn-100530
Oropharyngeal cancer cn-101521
Osteosarcoma cn-100049
Ovarian epithelial cancer cn-100950
Pheochromocytoma cn-102494
Plasma cell neoplasm cn-100281
Prostate cancer cn-101229
Testicular cancer cn-101121
Wilm's tumor cn-100719
New PDQ Patient Information Statement:
Carcinoma of unknown primary cn-203331
Changed patient information statements:
Adult Hodgkin's disease cn-200003
Chronic lymphocytic leukemia cn-201003
Colon cancer cn-200008
Laryngeal cancer cn-201519
Malignant mesothelioma cn-201071
Childhood brain tumor cn-200047
Childhood soft tissue sarcoma cn-203085
Neuroblastoma cn-200530
Osteosarcoma cn-200049
Wilm's tumor cn-200719
Changed cancer screening statements:
Screening for breast cancer cn-304723
Screening for cervical cancer cn-304728
Screening for prostate cancer cn-304727
Changed supportive care statements:
No changes.
Changed drug information statements:
No changes.
Request the Monthly PDQ Statement Changes ( cn-405001) for a description of
the changes in the statements listed above.
Request Changes to CancerNet (cn-400000) for a complete listing of changes to
CancerNet content for the current month.
Changed CancerNet News and PDQ database information:
NCI High Priority Trials cn-400007
Redistribution of CancerNet and CancerNet Availability cn-400030
New NCI Fact Sheets:
Personal Use of Hair Coloring Products and Risk of Cancer cn-600332
The following Fact Sheets were changed:
The National Cancer Institute Cancer Centers Program cn-600012
Q & A: Breast Cancer Prevention Trial cn-600041
Referral Information for the Breast Cancer Prevention Trial cn-400020
cn-400021
cn-400024
Referral Information for the Prostate Cancer Prevention Trial cn-400090
cn-400091
cn-400092
cn-400093
cn-400094
cn-400095
Q & A: Tamoxifen cn-600716
Questions and Answers About Adjuvant Therapy for Breast Cancer cn-600720
Antineoplastons/Dr. Stanislaw Burzynski cn-600091
The following fact sheets were deleted:
Canadian Study Prompts Health Officials to Review Mammography
Recommendations cn-600053
Detecting Breast Cancer cn-600057
New Cancer Therapy Applied to Brain Tumors in Animals cn-600079
Drug Blocks Spread of Kaposi's Sarcoma in Mice cn-600714
CANCERLIT Citations and Abstracts:
The Citations and Abstracts added to CANCERLIT in March will be available in
CancerNet on March 10, 1994.
Instructions:
To request the CancerNet Instructions and Contents List, send a
mail message, and in the body of the message, enter HELP.
Address the mail message to:
cancernet@icicb.nci.nih.gov
To request the modified statements, follow the above directions,
and in the body of the mail message, enter the statement code.
When requesting more than one statement, enter each code on a
separate line.
CancerNet statements are available in Spanish. To request the
Instructions and Contents List in Spanish, enter SPANISH in the
body of the mail message. If you would like to request the statements
in Spanish, substitute the prefix "cs-" in front of the number
e.g., cs-100022 to receive the statement on anal cancer in Spanish.
.
All of the physician and patient statements are available in Spanish.
Supportive care statements are now available in Spanish.
News items that are available in Spanish have a # next to the statement
title. Although both the English and Spanish are updated at the same
time each month, the Spanish statements do not reflect the changes made
in the English statements until the following month to allow time for
translation. If you are interested in requesting CancerNet statements
or news articles in Spanish, it is suggested that you request an updated
Contents List.
If you are redistributing the PDQ information you retrieve from
CancerNet to others at your location, or are interested in redistributing
the information from CancerNet, request the news article, Redistribution
of Cancernet (cn-400030), to find out about conditions that apply when
redistributing the information. This article also has information on
other sites providing access to CancerNet information.
Please send comments or questions to:
Cheryl Burg
NCI International Cancer Information Center
Internet: cheryl@icicb.nci.nih.gov
------------------------------
Date: Fri, 18 Mar 94 23:28:44 MST
From: mednews (HICNet Medical News)
To: hicnews
Subject: Institute of Tropical Medicine Epidemiological Bulletin 8 Jan 94
Message-ID: <L79eJc12w165w@stat.com>
IPK - EPIDEMIOLOGICAL BULLETIN Vol 4e / No.01
Date: 01/08/94
Institute of Tropical Medicine Pedro Kouri
National Epidemiology Office
Ministry of Public Health
------------------------------------------------------------
Cuba. Cases and Cumulative of selected notifiable diseases.
Week ending 01/08/94.
------------------------------------------------------------
DISEASES IN THIS WEEK CUMULATIVE
1992 1993 1992 1993
------------------------------------------------------------
TYPHOID FEVER * * * *
SHIGELLOSIS 4 1 4 1
AMEBIAN D. 47 * 47 *
TUBERCULOSIS 2 1 2 1
HANSEN DISEASE 1 1 1 1
PERTUSSIS * * * *
SCARLET FEVER 9 2 8 2
MENINGOCOCCAL M.(1) 3 1 3 1
MENINGOCCEMIES(1) * * * *
TETANUS * * * *
VIRAL M. 32 66 32 66
BACTERIAL M. 21 16 21 16
VARICELLA 705 380 705 380
MEASLES * * * *
RUBELLA * * * *
VIRAL HEPATITIS 301 148 301 148
MUMPS * * * *
MALARIA * 10 * 10
LEPTOSPIROSIS 5 13 5 13
SYPHILIS 118 217 118 217
GONORRHEA 391 317 391 317
ACUMINATA COND. 31 29 31 29
------------------------------------------------------------
Source: 1993, MND (Written Report) EIG-IPK.
1994, MND (Phone Report) EIG-IPK.
(1) DIS
* Means 0 reported case.
Medical Consultations of Acute Diarrhoeal Diseases.
Week ending 01/08/94
-------------------------------------------------------
AGE IN THIS WEEK CUMULATIVE
GROUPS 1993 1994 1993 1994
-------------------------------------------------------
<1 4007 3123 4007 3123
1 - 4 4816 4052 4816 4052
5 - 14 2886 2707 2886 2707
15 - 64 11025 9127 11025 9127
> 65 1198 1137 1198 1137
-------------------------------------------------------
Source: MND (Phone Report).
Medical Consultations of Acute Respiratory Infections.
Week ending 01/08/94
-------------------------------------------------------
AGE IN THIS WEEK CUMULATIVE
GROUPS 1993 1994 1993 1994
-------------------------------------------------------
<1 8208 7031 8208 7031
1 - 4 21200 15240 21200 15240
5 - 14 16829 12109 16829 12109
15 - 64 30124 21999 30124 21999
> 65 3655 2597 3655 2597
-------------------------------------------------------
Source: MND (Phone Report).
Notified Outbreaks. Week 01/01/94 - 01/05/94.
------------------------------------------------------------
DISEASES OUTBREAKS CASES PROVINCES
------------------------------------------------------------
F.T.D 2 46 HOLGUIN 1/33
SANT. DE CUBA 1/13
------------------------------------------------------------
LEPTOSPIROSIS 1 13 SANT. DE CUBA
------------------------------------------------------------
Source: DIS.
------------------------------------------------------------
This bulletin was prepared with the 60% of provinces-
days-information.
The offered indexes are provisionals and were taken from
the daily report of the Direct Information System (DIS)
remitted by Provincial Centers of Hygiene and
Epidemiology, from the weekly phone report of Mandatory
Notifiable Diseases (MND) remitted by National Statistics
Division of the Ministry of Public Health, and from the
Reference Laboratories of the Institute of Tropical
Medicine Pedro Kouri.
------------------------------------------------------------
This is the weekly IPK-Epidemiological Bulletin emitted
via Electronic Mail. The numbering plan agree with the
IPK-Epidemiological Bulletin edited by Institute of
Tropical Medicine Pedro Kouri and it is an abbreviated
version. If you are interested in receiving this
bulletin, please send your electronic address to:
Lic. Andres M. Alonso
Institute of Tropical Medicine Pedro Kouri
ipk-b@infomed.cu
------------------------------
End of HICNet Medical News Digest V07 Issue #09
***********************************************
---
Editor, HICNet Medical Newsletter
Internet: david@stat.com FAX: +1 (602) 451-1165
Bitnet : ATW1H@ASUACAD
-------------------------------------------------------------------------------